Loading provider…
Loading provider…
Dermatology Physician in Columbus, OH
NPI: 1073833042Primary Practice Location
OHIO STATE UNIVERSITY STATE HEALTH SYSTEM
1670 Upham Dr, Columbus, OH
Primary Employer
OSU Internal Medicine
wexnermedical.osu.edu
HQ Phone
Get MD Benjamin's Phone Numberphone_androidMobile
Get MD Benjamin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License

American Board of Dermatology
Dermatology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 234 | 325 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 136 | 206 |
| 3 | 17000Destruction of skin growth | 104 | 125 |
| 4 | 17003Destruction of 2-14 skin growths | 71 | 310 |
| 5 | 99451Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | 68 | 68 |
Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review.
Authors: Brady Evans, Brittany Dulmage
Journal: Drugs R D
Vancomycin-associated DRESS demonstrates delay in AST abnormalities.
Dupilumab for treatment of atopic dermatitis in patients living with HIV: a case series.
Authors: Jennifer Sopkovich, Lucia Seminario Vidal
Journal: Int J Dermatol
Publication Date: 2021-03-04
Lead Sponsor: OnQuality Pharmaceuticals (USA) LLC
Intervention / Treatment: DRUG: Vehicle Ointment, DRUG: OQL011
Lead Sponsor: Ohio State University
Collaborators: Eli Lilly and Company
Intervention / Treatment: BIOLOGICAL: Ixekizumab